Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Raymond, Jérémy H
7599  Ergebnisse:
Personensuche X
?
1

Targeting GPCRs and Their Signaling as a Therapeutic Option..:

Raymond, Jérémy H. ; Aktary, Zackie ; Larue, Lionel.
Cancers.  14 (2022)  3 - p. 706 , 2022
Link: https://doi.org/10.3390/..
 
?
2

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
Nature Communications.  12 (2021)  1 - p. , 2021
Link: https://doi.org/10.1038/..
 
?
3

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy H....
Cancers.  13 (2021)  6 - p. 1421 , 2021
Link: https://doi.org/10.3390/..
 
?
4

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13061421.  , 2021
Link: https://hal.science/hal-..
 
?
5

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13061421.  , 2021
Link: https://hal.science/hal-..
 
?
6

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-021-23973-5.  , 2021
Link: https://hal.science/hal-..
 
?
7

Efficacy of Targeted Radionuclide Therapy Using [(131)I]ICF..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003594/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
8

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-021-23973-5.  , 2021
Link: https://hal.science/hal-..
 
?
9

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211827/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
10

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13061421.  , 2021
Link: https://hal.science/hal-..
 
?
11

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
info:eu-repo/semantics/altIdentifier/doi/10.1038/s41467-021-23973-5.  , 2021
Link: https://hal.science/hal-..
 
?
12

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13061421.  , 2021
Link: https://hal.science/hal-..
 
?
13

Efficacy of Targeted Radionuclide Therapy Using [131I]ICF01..:

Akil, Hussein ; Quintana, Mercedes ; Raymond, Jérémy, H...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers13061421.  , 2021
Link: https://hal.science/hal-..
 
?
14

BRN2 is a non-canonical melanoma tumor-suppressor:

Hamm, Michael ; Sohier, Pierre ; Petit, Valérie...
Nature Communications; 12(1).  , 2021
Link: https://hdl.handle.net/2..
 
?
15

MicroRNAs in CSF as prodromal biomarkers for Huntington dis..:

Reed, Eric R. ; Latourelle, Jeanne C. ; Bockholt, Jeremy H....
Neurology.  90 (2018)  4 - p. , 2018
Link: https://doi.org/10.1212/..
 
1-15